|
Forecast Period
|
2026-2030
|
|
Market Size (2024)
|
USD
9.47 Billion
|
|
CAGR (2025-2030)
|
5.50%
|
|
Fastest Growing Segment
|
EP Ablation Procedures
|
|
Largest Market
|
Midwest
|
|
Market Size (2030)
|
USD 12.91 Billion
|
Market Overview
United States Electrophysiology Mapping
And Ablation Devices Market was valued at USD 9.47 Billion in 2024 and is
expected to reach USD 12.91 Billion by 2030 with a CAGR of 5.50%. Electrophysiology
(EP) mapping devices enable precise identification of irregular electrical
pathways in the heart, while ablation devices provide minimally invasive
treatment options by selectively destroying malfunctioning cardiac tissue.
The growth of this market in the U.S. is
driven by several factors, including the rising prevalence of cardiovascular
diseases, an aging population, and increasing awareness of advanced treatment
options that offer improved patient outcomes. However, the market faces
challenges including high device costs and the need for skilled operators to
perform complex procedures. Despite these barriers, ongoing research and
development, along with growing clinical evidence supporting the benefits of catheter-based
electrophysiology interventions, are expected to drive robust growth.
Key Market Drivers
Growth
in Healthcare Industry
In 2023, U.S. healthcare spending grew by 7.5%,
reaching USD 4.9 trillion, or approximately USD 14,570 per person. This
expenditure accounted for 17.6% of the country’s Gross Domestic Product (GDP).The robust
growth of the healthcare industry in the United States is a key driver fueling
the expansion of the electrophysiology (EP) mapping and ablation devices
market. Increasing prevalence of cardiovascular diseases, particularly
arrhythmias, combined with rising patient awareness and demand for minimally
invasive treatment options, has amplified the need for advanced EP
technologies.
Moreover, rising investments by hospitals and clinics
in state-of-the-art electrophysiology labs enable the adoption of sophisticated
mapping and ablation devices. Since 2006, private equity has invested nearly
USD 1 trillion in U.S. healthcare. While representing a small share of the sector,
these investments have been crucial funding research on diseases like
Alzheimer’s and Parkinson’s, expanding and upgrading facilities, modernizing
medical records and data, and supporting other essential improvements. As
healthcare providers focus on improving patient outcomes and reducing
procedural risks, the demand for innovative EP solutions continues to
accelerate, making the expanding healthcare industry a critical growth enabler
for this market.
Surge
in Technological Advancements
The United States electrophysiology mapping and
ablation devices market is being significantly propelled by rapid technological
advancements. Innovations such as 3D electroanatomical mapping systems,
robotic-assisted ablation technologies, and real-time imaging integration have
revolutionized the diagnosis and treatment of cardiac arrhythmias. For instance,
the CARTO 3 System Version 8 enhances CARTO mapping capabilities by delivering
advanced tools for physicians across various procedures. With improved signal
analysis, enhanced substrate characterization, and the integration of
ultrasound technology, Version 8 supports more efficient electrophysiology (EP)
procedures, reduces procedure time, and promotes consistent, reproducible
outcomes.
Moreover, the development of minimally invasive and
catheter-based ablation techniques has expanded treatment options, making
therapies less risky and more accessible. Enhanced software capabilities,
including artificial intelligence and machine learning algorithms, enable
precise mapping of complex arrhythmias, thereby increasing the efficacy of
interventions. As healthcare providers prioritize advanced, patient-centric
cardiac care, demand for sophisticated electrophysiology devices continues to
grow, positioning technological innovation as a key market driver.
Download Free Sample Report
Key Market Challenges
Shortage
of Skilled Electrophysiologists
A significant challenge facing the
United States Electrophysiology Mapping and Ablation Devices Market is the
shortage of skilled electrophysiologists. The complexity of electrophysiology
procedures demands highly trained and experienced specialists to accurately
interpret mapping data and perform precise ablation treatments. However, the
current supply of qualified electrophysiologists is insufficient to meet the
growing demand driven by the rising prevalence of cardiac arrhythmias and
expanding adoption of advanced mapping and ablation technologies.
This shortage creates operational
bottlenecks in healthcare facilities, potentially leading to longer patient
wait times, delayed treatments, and underutilization of sophisticated
electrophysiology equipment. Furthermore, the limited availability of skilled
professionals can increase procedural risks and impact overall treatment
outcomes, which in turn affects market growth and device adoption.
Key Market Trends
Growing
Use of Wearable Monitoring Devices
The increasing adoption of wearable
monitoring devices is emerging as a significant trend within the U.S.
electrophysiology mapping and ablation devices market. According to the 2023
Rock Health Digital Health Consumer Adoption Survey, 44% of Americans use
wearable health tracking devices, including smartwatches and smart rings, to
monitor various health metrics ranging from sleep patterns to heart rate. These
devices enable continuous, real-time cardiac monitoring, allowing for early
detection and precise diagnosis of arrhythmias outside traditional clinical
settings.
Enhanced patient convenience and
improved data accuracy offered by wearables facilitate better treatment
planning and timely intervention, which complements electrophysiology mapping
and ablation procedures. Integration of wearable technology with advanced
analytics and remote monitoring platforms is driving innovation and expanding
the scope of cardiac care. As both healthcare providers and patients prioritize
proactive disease management, the growing use of wearable monitoring devices is
expected to substantially influence market dynamics, promoting more
personalized and efficient electrophysiological treatments.
Segmental Insights
Procedure
Type Insights
Based on Procedure Type, EP Ablation
Procedures have emerged as the fastest growing segment in the United States Electrophysiology
Mapping And Ablation Devices Market in 2024. This is due to their increasing
adoption as a definitive treatment for a wide range of cardiac arrhythmias. The
growing prevalence of atrial fibrillation and other complex arrhythmias,
combined with rising awareness of the benefits of minimally invasive catheter
ablation, is driving demand. These procedures offer a targeted approach to
disrupt abnormal electrical pathways, significantly improving patient outcomes
and reducing the need for long-term medication.
Product
Insights
Based on Product, Mapping & Lab
Systems have emerged as the fastest growing segment in the United States Electrophysiology
Mapping And Ablation Devices Market during the forecast period. This is due to
a combination of technological advancements and rising healthcare demands.
Innovations in 3D electroanatomical mapping technologies have enhanced the
precision and efficiency of diagnosing cardiac arrhythmias, which in turn has
increased their adoption across healthcare facilities. The growing prevalence
of cardiac disorders in the population has further driven the need for accurate
and effective diagnostic tools, making mapping systems an essential component
in electrophysiological procedures.
Download Free Sample Report
Regional Insights
Based on Region, Midwest have emerged as
the dominating region in the United States Electrophysiology Mapping And
Ablation Devices Market in 2024. This is due to a confluence of strategic,
demographic, and economic factors. The region is home to a robust network of
advanced healthcare institutions and cardiac care centers that actively invest
in cutting-edge electrophysiology technologies to enhance patient outcomes. Additionally,
the Midwest’s growing aging population, coupled with a higher prevalence of
cardiac arrhythmias such as atrial fibrillation, has driven substantial demand
for EP mapping and ablation procedures.
Recent Development
- In October 2024, Abbott announced key
milestones advancing its expanding portfolio of pulsed field ablation (PFA)
solutions in electrophysiology. These include the early completion of
enrollment in the VOLT-AF IDE Study supporting the Volt PFA System, and the
launch of the FOCALFLEX trial to evaluate the TactiFlex Duo Ablation Catheter,
Sensor Enabled (SE), designed for treating patients with paroxysmal atrial
fibrillation. Together, these studies mark significant progress for Abbott’s
PFA catheter technologies, reinforcing their role as critical tools for
physicians managing abnormal heart rhythms such as atrial fibrillation (AFib).
- In November 2024, Johnson & Johnson
MedTech, a global leader in cardiac arrhythmia treatment, announced FDA
approval of the VARIPULSE Platform for managing drug-refractory paroxysmal
Atrial Fibrillation (AFib). The VARIPULSE Platform combines pulsed field
ablation (PFA) therapy with advanced mapping capabilities via the CARTO 3
System, the industry-leading 3D electroanatomical cardiac mapping solution.
Designed for seamless integration with CARTO, the VARIPULSE Platform enhances
the accuracy and safety of ablation procedures through precise energy delivery
and real-time catheter visualization.
- In May 2024, Biosense Webster, Inc., a
global leader in cardiac arrhythmia treatment and part of Johnson & Johnson
MedTech, announced the launch of CARTO 3 System Version 8, the latest iteration
of its industry-leading 3D heart mapping system used in cardiac ablation
procedures. This new version introduces advanced modules, including the CARTO
ELEVATE Module and CARTOSOUND FAM Module, designed to enhance efficiency,
accuracy, and procedural consistency for electrophysiologists treating atrial
fibrillation (AFib) and other arrhythmias.
- In October 2024, Boston Scientific
Corporation announced U.S. FDA approval of the navigation-enabled FARAWAVE NAV
Ablation Catheter for treating paroxysmal atrial fibrillation (AF), along with
510(k) clearance for the new FARAVIEW Software. Together, these technologies
enhance visualization during cardiac ablation procedures using the FARAPULSE
Pulsed Field Ablation (PFA) System. Exclusively compatible with Boston
Scientific’s existing cardiac mapping solutions and the newly introduced OPAL
HDx Mapping System, the FARAVIEW Software represents a significant advancement
in the company’s PFA portfolio. It enables magnetic tracking of the FARAWAVE
NAV Catheter, allowing physicians to visualize pulsed field application in real
time and guide therapy delivery with greater precision.
Key Market Players
- Siemens
Healthineers
- Koninklijke
Philips N.V.
- Abbott
Laboratories
- Johnson
& Johnson Services, Inc.
- GE
HealthCare
- Boston
Scientific Corporation
- Medtronic
Plc
- Biotronik
SE & Co KG
- MicroPort
Scientific Corporation
- CardioFocus,
Inc.
|
By Procedure Type
|
By Product
|
By Region
|
- EP Ablation Procedures
- Stand-Alone EP Diagnostic Procedures
- Others
|
- Mapping & Lab Systems
- Diagnostic Catheters
- Ablation Catheters
- Accessory Devices
- Others
|
- Northeast
- Midwest
- South
- West
|
Report Scope
In this report, the United States Electrophysiology
Mapping And Ablation Devices Market has been segmented into the following
categories, in addition to the industry trends which have also been detailed
below:
- United States Electrophysiology
Mapping And Ablation Devices Market, By Procedure Type:
o EP Ablation Procedures
o Stand-Alone EP Diagnostic Procedures
o Others
- United States Electrophysiology
Mapping And Ablation Devices Market, By Product:
o Mapping & Lab Systems
o Diagnostic Catheters
o Ablation Catheters
o Accessory Devices
o Others
- United States Electrophysiology
Mapping And Ablation Devices Market, By Region:
o Northeast
o Midwest
o South
o West
Competitive Landscape
Company Profiles: Detailed analysis of the major companies
present in the United States Electrophysiology Mapping And Ablation Devices
Market.
Available Customizations:
United States Electrophysiology Mapping And
Ablation Devices Market report with the given market data, TechSci Research
offers customizations according to a company's specific needs. The following
customization options are available for the report:
Company Information
- Detailed analysis and
profiling of additional market players (up to five).
United States Electrophysiology
Mapping And Ablation Devices Market is an upcoming report to be released soon.
If you wish an early delivery of this report or want to confirm the date of
release, please contact us at [email protected]